Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally.
The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic, which deliver non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface.
It also provides companion products, including the Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; the Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; the aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; the aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplify the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation.
In addition, the company offers the ProSoft cannula to provide gentle contact with the skin, and disposable products comprising single-use disposables and nasal interfaces, as well as the Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range.
Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
